Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-1-31
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0146-0404
pubmed:author
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
479-89
pubmed:meshHeading
pubmed-meshheading:18234989-Atrophy, pubmed-meshheading:18234989-Choroidal Neovascularization, pubmed-meshheading:18234989-Clinical Trials as Topic, pubmed-meshheading:18234989-Diabetic Retinopathy, pubmed-meshheading:18234989-Endpoint Determination, pubmed-meshheading:18234989-Humans, pubmed-meshheading:18234989-Macular Degeneration, pubmed-meshheading:18234989-National Institutes of Health (U.S.), pubmed-meshheading:18234989-Ophthalmology, pubmed-meshheading:18234989-Patient Satisfaction, pubmed-meshheading:18234989-Pigment Epithelium of Eye, pubmed-meshheading:18234989-Product Surveillance, Postmarketing, pubmed-meshheading:18234989-Research Design, pubmed-meshheading:18234989-Treatment Outcome, pubmed-meshheading:18234989-United States, pubmed-meshheading:18234989-United States Food and Drug Administration, pubmed-meshheading:18234989-Visual Acuity
pubmed:year
2008
pubmed:articleTitle
Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium.
pubmed:affiliation
Ophthalmic Unit, DCRI, Duke University Medical Center, Durham, NC 27710, USA. karl.csaky@duke.edu
pubmed:publicationType
Congresses, Research Support, N.I.H., Extramural